Udruženje hematologa i transfuziologa FBiH


Ova e-maila adresa je zaštićena od spambotova. Omogućite JavaScript da biste je vidjeli.


ESID 2021 Online Symposium

27-29 September 2021


Secondary immunodeficiencies become more and more common and widespread as they develop in the course of numerous diseases and result from a variety of therapeutic conditions. ESID 2021 is a unique multidisciplinary symposium bringing together professionals from different fields to share their expertise in the treatment and management of acquired immunodeficiencies.

Submit your research before 1 June 2021 and make an impact. Progress is in your hands.

For more information, please visit the Symposium website - https://2021.esidmeeting.org/

COVID-19 vaccination of patients with hematological diseases

Dear colleagues,
Aware that the place of hematology patients in national vaccination strategies is of increasing concern to many of you, we want to inform you that EHA has published two statements on its website:
Recommendations for COVID-19 vaccination in patients with hematologic cancer (LINK)
Recommendations for COVID-19 vaccination in patients with non-malignant diseases (LINK)

We would encourage you to share these with the health authorities in your country and urge them to:
1. Prioritize the vaccination of patients with hematologic malignancies.
2. Take into account the recommendations for specific groups of patients with non-malignant blood disorders.

Due to scarcity of data, no blanket vaccination strategy can be recommended for patients with non-malignant hematological diseases. EHA’s Scientific Working
Groups will be updating these recommendations once more evidence is available.
Patient-friendly versions of both statements are being prepared by the patient organizations and will be published on the EHA website soon.

Prof. John Gribben Prof. Elizabeth Macintyre
President President-elect

2021 European Hematology Exam

Dear coleagues,

We are pleased to inform you that the 2021 European Hematology Exam has been scheduled for June 3, from 11.00 – 13.30 CEST. We will again collaborate with national hematology societies for the organization of the parallel sessions.


iwCAR-T Virtual Meeting

VJHemOnc is the official media partner of the iwCAR-T Virtual Meeting!

This virtual workshop will cover trial updates and the latest thinking in CAR-T & cellular therapies from international leading experts in hematological oncology, featuring cutting edge presentations and live interactive panel discussions.

Register your place before the 29th of October!